Coeptis Therapeutics (COEP) Insider Trading & Ownership $11.16 +0.56 (+5.28%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$11.20 +0.04 (+0.36%) As of 08/8/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Coeptis Therapeutics (NASDAQ:COEP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage24.25%Number OfInsiders Buying(Last 3 Years)6Amount OfInsider Buying(Last 3 Years)$77.79KNumber OfInsiders Selling(Last 3 Years)0 Get COEP Insider Trade Alerts Want to know when executives and insiders are buying or selling Coeptis Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address COEP Insider Buying and Selling by Quarter Coeptis Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/12/2024Tara DesilvaDirectorBuy113$11.60$1,310.80 1/10/2024Brian CogleyCFOBuy250$13.40$3,350.00 1/8/2024David MehalickCEOBuy1,000$13.20$13,200.00 1/5/2024Daniel Alexander YeraceVPBuy542$13.80$7,479.60 1/5/2024David MehalickCEOBuy252$13.80$3,477.60 1/5/2024Gene SalkindDirectorBuy580$13.80$8,004.00 8/29/2023Gene SalkindDirectorBuy200$20.20$4,040.00 8/25/2023Gene SalkindDirectorBuy1,431$18.20$26,044.20 8/23/2023Chris CaliseDirectorBuy579$18.80$10,885.20 (Data available from 1/1/2013 forward) COEP Insider Trading Activity - Frequently Asked Questions Who is on Coeptis Therapeutics' Insider Roster? The list of insiders at Coeptis Therapeutics includes Brian Cogley, Chris Calise, Daniel Alexander Yerace, David Mehalick, Gene Salkind, and Tara Desilva. Learn more on insiders at COEP. What percentage of Coeptis Therapeutics stock is owned by insiders? 24.25% of Coeptis Therapeutics stock is owned by insiders. Learn more on COEP's insider holdings. Which Coeptis Therapeutics insiders have been buying company stock? The following insiders have purchased COEP shares in the last 24 months: Brian Cogley ($3,350.00), Chris Calise ($10,885.20), Daniel Alexander Yerace ($7,479.60), David Mehalick ($16,677.60), Gene Salkind ($38,088.20), and Tara Desilva ($1,310.80). How much insider buying is happening at Coeptis Therapeutics? Insiders have purchased a total of 4,947 COEP shares in the last 24 months for a total of $77,791.40 bought. Coeptis Therapeutics Key ExecutivesMr. David Mehalick (Age 55)Co-Founder, Chairman of the Board, CEO & President Compensation: $360kMs. Christine Elise Sheehy (Age 56)Co-Founder and VP of Compliance & Corporate Secretary Compensation: $151kMr. Daniel Alexander Yerace (Age 41)Co-Founder, VP of Operations & Director Compensation: $360kMr. Brian Cogley M.B.A. (Age 37)Chief Financial Officer Compensation: $208kDr. Colleen Delaney M.D. (Age 56)M.Sc., CSO & Chief Medical Officer Compensation: $360k More Insider Trading Tools from MarketBeat Related Companies Black Diamond Therapeutics Insider Trades Actuate Therapeutics Insider Trades Korro Bio Insider Trades Kyverna Therapeutics Insider Trades Nkarta Insider Trades FitLife Brands Insider Trades Nuvectis Pharma Insider Trades C4 Therapeutics Insider Trades IO Biotech Insider Trades Inhibikase Therapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:COEP) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coeptis Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coeptis Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free COEP Stock Alerts